Edwards Angell Palmer & Dodgeand Wilmer Cutler Pickering Hale and Dorrhave brokered the largest overseas acquisition by a Japanese pharmaceutical company. Takeda Pharmaceutical Company Limited, based in Osaka, agreed to pay $8.8 billion to acquire Cambridge, Mass.�based Millennium Pharmaceuticals, Inc., on Thursday.
Takeda’s legal team was led by Edwards Angell partners David Conlin, Bruce Raphael, Leonard Slap, Matthew Gardella, Albert Sokol, Eugene McDermott, Jr., Karl Fryzel, G. Scott Nebergall, and Benjamin Ferrucci. The firm has represented the company on several corporate and litigation matters in recent years, including Takeda’s 2005�06 patent infringement suit against generic drugmakers that challenged the Japenese company’s patent on a popular diabetes medicine. Takeda prevailed on that matter.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
